Author

Myra Ashraf

Columbia University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Synthetic Biology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Organism:E. coli· 2 Approach:experimental assay· 2 Assay:CRISPR screen· 1 Approach:deep learning· 1 Assay:metagenomics· 1 Organism:mouse· 1

Frequent Co-Authors

Jongwon ImiD· 2 shared Tal DaninoiD· 2 shared Adam M. FeistiD· 1 shared Alexander MichelsiD· 1 shared Alyssa Jasmine ChiangiD· 1 shared Amy LuiD· 1 shared Arjun Rohit AdapaiD· 1 shared Audrey Lam· 1 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersSynthetic Biology

Jongwon ImORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Expanding the therapeutic window of bacteria for cancer therapy

Jongwon Im, Meghna Komaranchath, Sophia Xi Windemuth, Hannah Kim, Xiaoyu Hu, Arjun Rohit Adapa, Myra Ashraf, Katherine A. Cummins, Courtney Coker, YoungUk Jang, 진하영, Kam W. Leong, Ronny Drapkin, Jeffrey N. Bruce, Peter Canoll, Tal Danino

This paper develops a tumor-targeting engineered bacterium that improves therapeutic efficacy and safety in cancer treatment.

bioRxiv · Oct 29, 2026 · PreprintSynthetic Biology

NanoPro - a Framework for Probiotically-Guided Nanovector Therapy

Alexander Michels, Azra Haseki, Myra Ashraf, Audrey Lam, Kailyn R Grant, Amy Lu, Rosa L. Vincent, Jongwon Im, Zakary S. Singer, Edward R. Ballister, Tal Danino

The paper introduces NanoPro, a nanovector therapy platform using probiotically-released tumor-binding tags to target antigenically indistinct tumors, demonstrating in vitro efficacy with high transduction rates.

bioRxiv · Oct 29, 2026 · PreprintSynthetic Biology

Evolved microbial diversity enables combinatoric biosensing in complex environments

Alyssa Jasmine Chiang, Nicholas Csicsery, Richard O’Laughlin, Leo A. Baumgart, Elizabeth Stasiowski, Phuc Nguyen, Austin C.V. Doughty, Myra Ashraf, Raegan Mink, Elina C. Olson, Michael Ferry, Adam M. Feist, Nan Hao, Karsten Zengler, Jeff Hasty

The paper develops a framework using evolved microbial diversity and machine learning to enable combinatoric biosensing of multiple analytes in complex environments.

Cell Systems · Aug 18, 2026Peer-reviewedBioengineering